Showing 109 of 109on this page. Filters & sort apply to loaded results; URL updates for sharing.109 of 109 on this page
Inicio | BIOATL
Bioatl
Portfolio Companies past | HBM Partners
BioAtla rakes in $72.5M Series D, advancing research for pH-detecting ...
BioAtla Axes 70% of Staff, Exploring Strategic Options Amidst Industry ...
BioAtla (NASDAQ:BCAB) Raised to Sell at Wall Street Zen - American ...
BioAtla (BCAB.O) Plummets 15% Intraday—What’s Behind the Sudden Drop?
BioAtla logo in transparent PNG and vectorized SVG formats
BioAtla Shares Surge on Promising Clinical Trial Data - Stocks Today
Impressive Survival Data Sparks Rally for BioAtla Shares - Stocks Today
BioAtla Announces Upcoming Poster Presentation at the 39th Society for ...
BioAtla Stock Slips Premarket After Early Pop As Investors Weigh $40M ...
Bioatla Shares Surge on Strong Clinical and Financial Results - Stocks ...
What Is BioAtla’s IPO Date and Price?
BioAtla & GATC Health: Oz-V Phase III Oncology Trial
BioAtla, Inc. (BioAtla, Inc.) - 药物管线_专利_临床试验_投融营收_最新药物:Ozuriftamab ...
BioAtla to Complete Merger with BA Merger Sub on April 6
BioAtla's New Funding: A Double-Edged Sword for Shareholders - Stocks Today
BioAtla Virtual R&D Day: BA3071 CAB-CTLA-4 Phase 1 Data Review in ...
FDA assents to BioAtla's IND for BA3011 - Pharma Journalist
BioAtla’s Ozuriftamab Vedotin Receives FDA Fast Track Designation for ...
生物科技公司:BioAtla, Inc.(BCAB) | 美股之家 - 港股美股开户投资百科全书
Yong Ben appointed Chief Medical Officer of BioAtla - Pharma Journalist
Corporate Partnership - Life Science Cares
BioAtla在D輪融資中籌資7250萬美元 | NAI 500
BioAtla | | The Pharmaletter | The Pharmaletter
BioAtla - News, Layoffs, Mergers and Acquisitions and Locations - Usearch
BioAtla Logo im transparenten PNG- und vektorisierten SVG-Format
BioAtla | | The Pharmaletter
BioAtla and GATC Health Announce $40M SPV Transaction to Advance ...
BioAtla Virtual KOL Event - IASLC Data Review: BA3011 in Non-Small Cell ...
BioAtla Careers | Levels.fyi
BioAtla-JPM-202401 - 医微客
BioAtla - Investor Presentations and Pitch Decks | Slidebook.io
BioAtla posts 2025 loss, starts strategic review | BCAB 8-K Filing
BioAtla's Big Reveal: What to Expect from Q4 2024 Earnings
BioAtla August 2025 slides: promising clinical data amid financial ...
BioAtla, Inc. | LinkedIn
BioAtla, Inc. (NASDAQ:BCAB) Q3 2024 Earnings Call Transcript - Insider ...
BioAtla Investor Presentation Deck | Slidebook.io
BioAtla, Inc. (BCAB): Share Price, DCF Valuation & Analysis | AllInvestView
Post-IPO Equity - BioAtla
BioAtla pursues strategic review, cancer pipeline focus | BCAB Annual ...
BioAtla (BCAB) Stock Forecast and Price Target 2026
Lung investor presentations and pitch decks | Slidebook
BIO-ATLE®SR - Biobase Sweden
BioAtla, GATC form $40M SPV to advance ozuriftamab — Phase 3 planned in ...
BioAtla out-licenses T cell therapy in $134 million deal ...
BioAtla to Host Q3 Financial Results Call on Nov. 13 | BCAB Stock News
BioAtla Inc. (BCAB) | IPO 2020
BIO-ATLE®R – Biobase Sweden
BioAtla Is the Latest Biotech IPO to Pop. It Closed Up 72%. - Barron's
BioAtla broad patent for Antibody Development
BioAtla Announces Share Consolidation | INN
BIOATLA Trademark | Trademarkia
BioAtla (BCAB.O) Plunges 15%—What’s Behind the Sharp Move?
Discovery linking gut bacteria to cancer treatment wins the Bial Award ...
BioAtlas」をApp Storeで
Contact - ECOPRE.Ge
BioAtlas on the App Store
HCW starts BioAtla at buy; PT $25 - BioTuesdays
ATLATL and Samsung Bioepis to accelerate early-stage biotech innovation ...
Portal TecnoAgrícola
BioAtla Layoffs - TheLayoff.com
ATUL BIOPEARL – Agripariwar
BioAtlas for Institutions - Apps on Google Play
Como posso atualizar a versão do BioAtlas? – Medical Harbour - Português
ATL BIOTIC PRE 30CPS
BioAtla Announces Clinical Collaboration with Bristol Myers Squibb to ...
BIOALGAL - Leitat Technological Center
Descarga de APK de BioAtlas para Android
BioAtla (BCAB) Q2 2025 Earnings Results & Call Transcript
BCAB Earnings Q2 2026: BioAtla Quarterly Results Analysis
BioAtla announces chief medical officer resignation, updates executive ...
BioAtla Secures $5 Million Initial Funding for Phase 3 Trial of ...
BioAtla Announces CMO Departure and Updates Retention Bonuses for CEO ...
Form 8K Bioatla Inc For: 29 September By Investing.com
BCAB 8-K Filings - BIOATLA INC SEC 8-K
BIOATLA INC by BioAtla, Inc. Corporate Event Calendar | OTC:BCAB | Benzinga
BioAtla (BCAB) sets $40M SPV to fund Phase 3 Oz-V OPSCC trial | BCAB ...
BioAtla, Inc. (BCAB): Among Michael Burry’s Top 10 Stock Picks Heading ...
BioAtla, Inc. Announces Registered Direct Offering to Advance Two Mid ...
BioAtla signs stock sale agreement for up to $40M | BCAB 8-K Filing
Bioatla Inc Share Price History (BCAB) - Buy Bioatla Inc Shares (BCAB.L ...
BCAB Investor Relations & Company Overview - Bioatla Inc - Alpha Spread
BioAtla launches strategic review, cuts 70% of staff | BCAB 8-K Filing
BioAtla, Inc. (BCAB) Latest Press Releases | Seeking Alpha
裁 70% 员工!BioAtla 撑不下去了?|医药|实体瘤|生物制品|候选药物|bioatla_网易订阅
BioAtla - BCAB - Stock Price Today - Zacks
BCAB | Bioatla Inc股市 - Investing.com
Eshallgo Inc. Shareholders Approve 5-for-1 Stock Consolidation and ...
Bioatla Inc投融资最新情况_摩熵医药
BCAB Stock Price | BioAtla Inc. Stock Quote (U.S.: OTC) | MarketWatch